Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus sufentanil for early recovery after laparoscopic nephrolithotomy
ChiCTR1900026827Phase 4Not yet recruiting
- Sponsor
- People's Hospital of Kizilsu Kirghiz Autonomous Prefecture
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil and sufentanil in nephrolithiasis (2 arms), sponsored by People's Hospital of Kizilsu Kirghiz Autonomous Prefecture. Primary endpoint: Ramsay score. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
remifentanilsufentanil
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on ChiCTR1900026827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026827.